SCRT1: A Potential Drug Target and Biomarker (G83482)
SCRT1: A Potential Drug Target and Biomarker
SCRT1 (short for Secure Chemical Releasing Transport-1) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. SCRT1 is a transmembrane protein that is expressed in various tissues and cells in the body, including the brain, pancreas, and gastrointestinal tract.
The potential drug target for SCRT1 is its role in the transport of various molecules, including drugs, toxins, and other substances across cell membranes. SCRT1 has been shown to play a crucial role in the production and release of neurotransmitters, such as dopamine and serotonin, which are involved in various brain functions.
Additionally, SCRT1 has been linked to the transport of other molecules that are involved in diseases, such as cancer. For example, studies have shown that high levels of SCRT1 have been observed in various types of cancer, and that inhibiting SCRT1 may be a potential strategy for cancer treatment.
Another potential benefit of targeting SCRT1 is its potential as a biomarker. The development of new diagnostic tests and biomarkers for diseases is a major area of research and development in the field of medicine. SCRT1 has the potential to serve as a biomarker for various diseases, including cancer, due to its expression in different tissues and its involvement in the transport of molecules that are involved in disease.
In conclusion, SCRT1 is a gene that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in the body and its potential as a therapeutic target. If its potential as a drug target and biomarker is confirmed, SCRT1 may be a valuable tool in the development of new treatments for a variety of diseases.
Protein Name: Scratch Family Transcriptional Repressor 1
Functions: Transcriptional repressor that binds E-box motif CAGGTG. Can modulate the action of basic helix-loop-helix (bHLH) transcription factors, critical for neuronal differentiation
More Common Targets
SCRT2 | SCT | SCTR | SCUBE1 | SCUBE2 | SCUBE3 | SCXA | SCYL1 | SCYL2 | SDAD1 | SDAD1-AS1 | SDAD1P1 | SDC1 | SDC2 | SDC3 | SDC4 | SDCBP | SDCBP2 | SDCBP2-AS1 | SDCBPP2 | SDCCAG8 | SDE2 | SDF2 | SDF2L1 | SDF4 | SDHA | SDHAF1 | SDHAF2 | SDHAF3 | SDHAF4 | SDHAP1 | SDHAP2 | SDHAP3 | SDHAP4 | SDHB | SDHC | SDHD | SDHDP1 | SDHDP2 | SDK1 | SDK1-AS1 | SDK2 | SDR16C5 | SDR16C6P | SDR39U1 | SDR42E1 | SDR42E2 | SDR9C7 | SDS | SDSL | SEBOX | SEC11A | SEC11B | SEC11C | SEC13 | SEC14L1 | SEC14L1P1 | SEC14L2 | SEC14L3 | SEC14L4 | SEC14L5 | SEC14L6 | SEC16A | SEC16B | SEC1P | SEC22A | SEC22B | SEC22C | SEC23A | SEC23B | SEC23IP | SEC24A | SEC24AP1 | SEC24B | SEC24B-AS1 | SEC24C | SEC24D | SEC31A | SEC31B | SEC61A1 | SEC61A2 | SEC61B | SEC61G | SEC62 | SEC63 | SEC63P2 | SECISBP2 | SECISBP2L | SECTM1 | Segment polarity protein dishevelled homolog | SEH1L | SEL1L | SEL1L2 | SEL1L3 | SELE | SELENBP1 | SELENOF | SELENOH | SELENOI | SELENOK